Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Dosing of Biologics in Juvenile Idiopathic Arthritis: Is the Sky the Limit?

FEMKE H.M. PRINCE and DANIEL H. SOLOMON
The Journal of Rheumatology October 2013, 40 (10) 1643-1645; DOI: https://doi.org/10.3899/jrheum.130875
FEMKE H.M. PRINCE
Department of Paediatrics, Academic Medical Centre, Emma Children’s Hospital, Amsterdam, Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: femkeprince@gmail.com
DANIEL H. SOLOMON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 40 no. 10 1643-1645
DOI 
https://doi.org/10.3899/jrheum.130875
PubMed 
24085753

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Published online October 1, 2013.

Copyright & Usage 
© 2013

Author Information

  1. FEMKE H.M. PRINCE, MD, PhD, MSCE⇑
  1. Department of Paediatrics, Academic Medical Centre, Emma Children’s Hospital, Amsterdam, Netherlands;
  1. Address correspondence to Dr. F.H.M. Prince, Academic Medical Centre, Emma Children’s Hospital, Department of Pediatrics, H7-270, Meibergdreet 9, Amsterdam, 1105 A2, the Netherlands. E-mail: femkeprince{at}gmail.com
  1. DANIEL H. SOLOMON, MD, MPH
  1. Divisions of Rheumatology, Immunology and Allergy and Pharmacoepidemiology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA

Article usage

Article usage: September 2013 to January 2023

AbstractFullPdf
Sep 2013220
Oct 201384296120
Nov 2013192326
Dec 2013161211
Jan 2014599
Feb 201416417
Mar 2014794
Apr 20145107
May 20144228
Jun 2014544
Jul 20141254
Aug 20143411
Sep 2014533
Oct 2014364
Nov 2014232
Dec 2014121
Jan 2015334
Feb 2015212
Mar 20151266
Apr 2015165
May 2015463
Jun 20151243
Jul 2015722
Aug 20156511
Sep 2015562
Oct 2015536
Nov 20151025
Dec 2015363
Jan 2016424
Feb 20165510
Mar 2016538
Apr 2016696
May 2016365
Jun 2016811
Jul 2016703
Aug 2016912
Sep 2016882
Oct 20161270
Nov 2016503
Dec 2016271916
Jan 201751711
Feb 20174134
Mar 2017567
Apr 201761317
May 20171136
Jun 20174123
Jul 2017295
Aug 20170125
Sep 20173132
Oct 20173175
Nov 20171164
Dec 20173112
Jan 20185221
Feb 2018394
Mar 20183171
Apr 20182163
May 20184188
Jun 20182116
Jul 20184260
Aug 20181114
Sep 20181133
Oct 20181133
Nov 20183345
Dec 20181114
Jan 2019462
Feb 2019054
Mar 2019154
Apr 2019147
May 2019176
Jun 2019066
Jul 2019242
Aug 2019065
Sep 2019042
Oct 20192157
Nov 20193117
Dec 20193103
Jan 2020181
Feb 2020192
Mar 2020151
Apr 20200135
May 2020050
Jun 2020123
Jul 2020093
Aug 20202810
Sep 2020047
Oct 2020488
Nov 20200153
Dec 20202165
Jan 202111112
Feb 20210197
Mar 20210114
Apr 20211122
May 20211528
Jun 20210197
Jul 2021185
Aug 2021046
Sep 20211126
Oct 202101023
Nov 20210517
Dec 20210107
Jan 2022096
Feb 2022163
Mar 2022033
Apr 2022152
May 20220413
Jun 2022159
Jul 2022027
Aug 2022075
Sep 2022079
Oct 2022126
Nov 2022055
Dec 2022052
Jan 20230286

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 40, Issue 10
1 Oct 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Dosing of Biologics in Juvenile Idiopathic Arthritis: Is the Sky the Limit?
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Dosing of Biologics in Juvenile Idiopathic Arthritis: Is the Sky the Limit?
FEMKE H.M. PRINCE, DANIEL H. SOLOMON
The Journal of Rheumatology Oct 2013, 40 (10) 1643-1645; DOI: 10.3899/jrheum.130875

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Dosing of Biologics in Juvenile Idiopathic Arthritis: Is the Sky the Limit?
FEMKE H.M. PRINCE, DANIEL H. SOLOMON
The Journal of Rheumatology Oct 2013, 40 (10) 1643-1645; DOI: 10.3899/jrheum.130875
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • From Prediction Tools to Precision Medicine in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
  • Optimizing Care for Pregnancy in Rheumatic Diseases: Barriers and Potential Solutions
  • High Frequency of Foot Insufficiency Fractures in Patients With Rheumatic Diseases Referred for Magnetic Resonance Imaging: What Is the Clinical Relevance?
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire